358 related articles for article (PubMed ID: 28618015)
21. Macrophage activity assessed by soluble CD163 in early rheumatoid arthritis: association with disease activity but different response patterns to synthetic and biologic DMARDs.
Greisen SR; Møller HJ; Stengaard-Pedersen K; Hetland ML; Hørslev-Petersen K; Junker P; Østergaard M; Hvid M; Deleuran B
Clin Exp Rheumatol; 2015; 33(4):498-502. PubMed ID: 25962601
[TBL] [Abstract][Full Text] [Related]
22. Circulating Macrophage Activation Markers Predict Transplant-Free Survival in Patients With Primary Sclerosing Cholangitis.
Bossen L; Vesterhus M; Hov JR; Färkkilä M; Rosenberg WM; Møller HJ; Boberg KM; Karlsen TH; Grønbæk H
Clin Transl Gastroenterol; 2021 Mar; 12(3):e00315. PubMed ID: 33646203
[TBL] [Abstract][Full Text] [Related]
23. Soluble CD163, a specific macrophage activation marker, is decreased by anti-TNF-α antibody treatment in active inflammatory bowel disease.
Dige A; Støy S; Thomsen KL; Hvas CL; Agnholt J; Dahlerup JF; Møller HJ; Grønbaek H
Scand J Immunol; 2014 Dec; 80(6):417-23. PubMed ID: 25346048
[TBL] [Abstract][Full Text] [Related]
24. Improved prediction of mortality by combinations of inflammatory markers and standard clinical scores in patients with acute-on-chronic liver failure and acute decompensation.
Grønbaek H; Møller HJ; Saliba F; Zeuzem S; Albillos A; Ariza X; Graupera I; Solà E; Amoros A; Pavesi M; Bossen L; Jalan R; Gines P; Arroyo V
J Gastroenterol Hepatol; 2021 Jan; 36(1):240-248. PubMed ID: 32478437
[TBL] [Abstract][Full Text] [Related]
25. Macrophage Activation Markers Predict Liver-Related Complications in Primary Biliary Cholangitis.
Fujinaga Y; Namisaki T; Tsuji Y; Suzuki J; Murata K; Takeda S; Takaya H; Inoue T; Noguchi R; Fujimoto Y; Enomoto M; Nishimura N; Kitagawa K; Kaji K; Kawaratani H; Akahane T; Mitoro A; Yoshiji H
Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077228
[TBL] [Abstract][Full Text] [Related]
26. Single-centre experience of the macrophage activation marker soluble (s)CD163 - associations with disease activity and treatment response in patients with autoimmune hepatitis.
Grønbaek H; Kreutzfeldt M; Kazankov K; Jessen N; Sandahl T; Hamilton-Dutoit S; Vilstrup H; J Møller H
Aliment Pharmacol Ther; 2016 Nov; 44(10):1062-1070. PubMed ID: 27679428
[TBL] [Abstract][Full Text] [Related]
27. Soluble CD163, a marker of Kupffer cell activation, is related to portal hypertension in patients with liver cirrhosis.
Grønbaek H; Sandahl TD; Mortensen C; Vilstrup H; Møller HJ; Møller S
Aliment Pharmacol Ther; 2012 Jul; 36(2):173-80. PubMed ID: 22591184
[TBL] [Abstract][Full Text] [Related]
28. Soluble mannose receptor as a predictor of prognosis of hepatitis B virus-related acute-on-chronic liver failure.
Li TP; Guan SH; Wang Q; Chen LW; Yang K; Zhang H
World J Gastroenterol; 2019 Oct; 25(37):5667-5675. PubMed ID: 31602166
[TBL] [Abstract][Full Text] [Related]
29. Expression of soluble sCD163 in serum of psoriatic patients is modulated by Goeckerman therapy.
Kondelkova K; Krejsek J; Borska L; Fiala Z; Hamakova K; Andrys C
Allergol Immunopathol (Madr); 2013; 41(3):158-62. PubMed ID: 22765877
[TBL] [Abstract][Full Text] [Related]
30. Elevated Serum Levels of Soluble CD163 in Polymyositis and Dermatomyositis: Associated with Macrophage Infiltration in Muscle Tissue.
Peng QL; Zhang YL; Shu XM; Yang HB; Zhang L; Chen F; Lu X; Wang GC
J Rheumatol; 2015 Jun; 42(6):979-87. PubMed ID: 25877505
[TBL] [Abstract][Full Text] [Related]
31. Macrophage activation marker, soluble CD163, is an independent predictor of short-term mortality in patients with cirrhosis and bacterial infection.
Tornai T; Vitalis Z; Sipeki N; Dinya T; Tornai D; Antal-Szalmas P; Karanyi Z; Tornai I; Papp M
Liver Int; 2016 Nov; 36(11):1628-1638. PubMed ID: 27031405
[TBL] [Abstract][Full Text] [Related]
32. Soluble CD163 in patients with liver diseases: very high levels of soluble CD163 in patients with fulminant hepatic failure.
Hiraoka A; Horiike N; Akbar SM; Michitaka K; Matsuyama T; Onji M
J Gastroenterol; 2005 Jan; 40(1):52-6. PubMed ID: 15692789
[TBL] [Abstract][Full Text] [Related]
33. Macrophage Markers Are Poorly Associated With Liver Histology in Children With Nonalcoholic Fatty Liver Disease.
Kazankov K; Alisi A; Møller HJ; De Vito R; Rittig S; Mahler B; Nobili V; Grønbæk H
J Pediatr Gastroenterol Nutr; 2018 Nov; 67(5):635-642. PubMed ID: 30074574
[TBL] [Abstract][Full Text] [Related]
34. Effects of lifestyle intervention on soluble CD163, a macrophage activation marker, in patients with non-alcoholic fatty liver disease.
Rødgaard-Hansen S; St George A; Kazankov K; Bauman A; George J; Grønbæk H; Jon Møller H
Scand J Clin Lab Invest; 2017 Nov; 77(7):498-504. PubMed ID: 28715286
[TBL] [Abstract][Full Text] [Related]
35. High hepatic macrophage activation and low liver function in stable Wilson patients - a Danish cross-sectional study.
Björklund J; Laursen TL; Sandahl TD; Møller HJ; Vilstrup H; Ott P; Grønbæk H
Orphanet J Rare Dis; 2018 Sep; 13(1):169. PubMed ID: 30241550
[TBL] [Abstract][Full Text] [Related]
36. Increased concentrations of the soluble mannose receptor in serum from patients with pneumococcal bacteraemia, and prediction of survival.
Rødgaard-Hansen S; Rafique A; Weis N; Wejse C; Nielsen H; Pedersen SS; Møller HJ; Kronborg G
Infect Dis (Lond); 2015 Apr; 47(4):203-8. PubMed ID: 25650730
[TBL] [Abstract][Full Text] [Related]
37. Association of serum macrophage-mannose receptor CD206 with mortality in idiopathic pulmonary fibrosis.
Zou R; Gui X; Zhang J; Tian Y; Liu X; Tian M; Chen T; Wu H; Chen J; Dai J; Cai H
Int Immunopharmacol; 2020 Sep; 86():106732. PubMed ID: 32622200
[TBL] [Abstract][Full Text] [Related]
38. Association of CD163+ macrophages and local production of soluble CD163 with decreased lymphocyte activation in spondylarthropathy synovitis.
Baeten D; Møller HJ; Delanghe J; Veys EM; Moestrup SK; De Keyser F
Arthritis Rheum; 2004 May; 50(5):1611-23. PubMed ID: 15146432
[TBL] [Abstract][Full Text] [Related]
39. Identification of mannose receptor and CD163 as novel biomarkers for colorectal cancer.
Ding D; Yao Y; Yang C; Zhang S
Cancer Biomark; 2018 Feb; 21(3):689-700. PubMed ID: 29226859
[TBL] [Abstract][Full Text] [Related]
40. Serum levels of soluble CD163 as a specific marker of macrophage/monocyte activity in sarcoidosis patients.
Tanimura H; Mizuno K; Okamoto H
Sarcoidosis Vasc Diffuse Lung Dis; 2015 Jul; 32(2):99-105. PubMed ID: 26278688
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
